...
首页> 外文期刊>Endoscopy International Open >Endoscopic ultrasound-guided radiofrequency ablation for hepatocellular carcinoma in cirrhosis: a case report test for efficacy and future perspectives
【24h】

Endoscopic ultrasound-guided radiofrequency ablation for hepatocellular carcinoma in cirrhosis: a case report test for efficacy and future perspectives

机译:肝硬化中肝细胞癌的内窥镜超声引导射频消融:疗效和未来观点的案例报告试验

获取原文
           

摘要

Background?The percutaneous approach allows for effective and safe treatment of liver lesions. But in case of subcapsular or left segments location, this approach seems to be less effective or unsafe. Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) is a new technique used to treat pancreatic and neuroendocrine tumors in patients unfit for surgery. Methods?Hereby, we describe the case of a 70-year-old patient with cirrhosis with a large subcapsular hepatocellular carcinoma (HCC) in II-III-IVb segments, in which surgery or percutaneous therapies were not feasible, treated with EUS-RFA. The HCC was treated using an EUS-RFA (EUSRA) system, which consists of a 19G water-cooled monopolar RFA needle and a dedicated generator system. Results?After a multidisciplinary discussion, the lesion was ablated in two different sessions, which resulted in destruction of about 70?% of neoplastic tissue. A second step surgery was required but initially refused by the patient. Conclusions?EUS-RFA could be an effective way to treat left hepatic lesions not manageable with conventional percutaneous methods. This case report does not highlight concerns about safety of this approach and this observation needs to be validated in a larger cohort of patients with cirrhosis.
机译:背景?经皮方法允许有效和安全地治疗肝脏病变。但在亚面包层或左段地点的情况下,这种方法似乎效果较小或不安全。内窥镜超声引导的射频消融(EUS-RFA)是一种用于治疗患者在不适合手术的胰腺癌和神经内分泌肿瘤的新技术。方法?特此,我们描述了在II-III-IVB区段中具有大亚皮肝细胞癌(HCC)的肝硬化的70岁患者的情况,其中手术或经皮疗法不可行,用EUS-RFA处理。 HCC使用EUS-RFA(EUSRA)系统进行处理,该系统由19G水冷单极RFA针和专用发电机系统组成。结果?在多学科讨论后,病变在两个不同的会话中被烧蚀,导致肿瘤组织的约70?%的破坏。需要第二步手术,但最初被患者拒绝。结论?EUS-RFA可以是治疗左肝病变的有效方法,不能与常规经皮方法可管理。本案例报告并不突出对这种方法的安全性的担忧,并且需要在肝硬化患者的较大患者中验证这种观察。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号